Culturally competent behavioral health provider ReKlame Health is rolling out an in-home program for addiction medicine care in New York City. For patients diagnosed with alcohol use disorder, a registered nurse will come to their home on a monthly basis to administer Naltrexone LAI, a medicine that helps stop cravings for opioids and alcohol.
The American Medical Association recently released its comments on the DEA’s proposed rules for controlled substance prescribing via telemedicine. Many telehealth providers are supportive of the organization's recommendations, such as its suggestion to extend the timeframe patients have to refill their buprenorphine prescription after their initial supply is prescribed via telemedicine.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
By joining Cigna’s network, ReKlame’s services are now available to members in New York, New Jersey and Florida. The company is focused on serving underrepresented communities and treats several conditions, including depression, anxiety, addiction, ADHD, trauma and mood disorders.
ReKlame Health launched in 2020 to provide affordable, culturally competent behavioral healthcare to Black and Brown communities in New York. On Monday, the startup announced it is now serving patients in two additional states — New Jersey and Florida.